MedTrace Logo

Hepatocellular Carcinoma Registry for Turkey (3K Trial)

NCT01473121 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2019-07-05

No results posted yet for this study

Summary

This registry study is national, multi-center, prospective study without any interventions to the treatment strategies and/or decisions of the investigators. It is designed in order to determine the general profile of HCC patients in Turkey. Socio-demographic characteristics, family history, medical history and treatment pattern of HCC patients will be evaluated.

Conditions

Interventions

OTHER

No Intervention

All treatment options (inc. surgery, TACE, drugs) will be registered.

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-13
Primary Completion
2017-06-30
Completion
2018-07-12

Countries

  • Turkey (Türkiye)

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01473121 on ClinicalTrials.gov